References
- Schena F.P., Gesualdo L., Grandaliano G., Montinaro V. Progression of renal damage in human glomerulonephritides: is there sleight of hand in winning the game. Kidney Int. 1997; 52: 1439–1457
- Ruiz-Ortega M., Egido J. Angioensin II modulates cell growth-related events and thesis of matrix proteins in renal interstitial fibroblasts. Kidney Int. 1979; 52: 1497–1510
- Futrakul P., Sitprija V., Yenrudi S. Glomerular endothelial dysfunction determines disease progression: a hypothesis. Am. J. Nephrol. 1997; 17: 533–540
- Futrakul P., Poshyachinda M., Yenrudi S. Intrarenal hemodynamic abnormality in severe form of glomerulonephritis: therapeutic benefit with vasodilators. J. Med. Assoc. Thai. 1992; 75: 375–385
- Futrakul P., Futrakul N., Sitprija V. Enhanced renal perfusion improves function in severe nephrosis with focal segmental glomerulosclerosis. Nephrology 1995; 1: 51–57
- Pisoni R., Faraone R., Ruggenenti P., Remuzzi G. Inhibitors of the reninangiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency. J. Nephrol. 2002; 15: 428–430
- Scarpelli P.T., Gallo M., De Cesaris F. Continuing follow-up of malignant hypertension. J. Nephrol. 2002; 15: 431–437
- Guijarro C., Egido J. Transcription factor-kappa B and renal disease. Kidney Int. 2001; 59: 415–424
- Wei Z., Costa K., Al-Medhi A.B., Dodia C., Muzykantor V., Fisher A.B. Simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling. Circ. Res. 1999; 85: 682–689
- Futrakul N., Yenrudi S., Sensirivatana R. Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephrotic syndrome. Ren. Fail. 2000; 22: 329–335
- Futrakul P., Sitprija V., Sensirivatana R., Poshyachinda M., Futrakul N. Microcirculatory Failure and Progressive Renal Disease. Proceedings 3rd Asian Congress for Microcirculation, Bangkok, 1997. Monduzzi Editore, pp. 53–58
- Futrakul N., Tosukhowong P., Valyapongpichit Y., Tipprukmas N., Futrakul P., Patumraj S. Oxidative stress and hemodynamic maladjustment in chronic renal disease: a therapeutic implication. Ren. Fail. 2002; 24: 433–445
- Futrakul P., Yenrudi S., Futrakul N. Tubular function and tubulointerstitial disease. Am. J. Kidney Dis. 1999; 33: 886–891
- Futrakul N., Yenrudi S., Futrakul P. Peritubular capillary flow and tubular unction in idiopathic nephrotic syndrome. Nephron 2000; 85: 181–182
- Komine N., Khang S., Wead L.M., Blantz R.C., Gabbai F.B. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels. Am. J. Kidney Dis. 2002; 39: 159–164
- Remuzzi A., Gagliardini E., Donadoni C. Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kidney Int. 2002; 62: 885–894